Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
以安慰剂为平行对照评价双翘感冒颗粒治疗普通感冒(风热证)伴中重度发热的有效性及安
全性的随机、双盲单模拟、剂量探索的多中心Ⅱ期临床试验
[Translation] A randomized, double-blind, single-dummy, dose-finding, multicenter phase II clinical trial to evaluate the efficacy and safety of Shuangqiao Ganmao Granules in the treatment of common cold (wind-heat syndrome) with moderate to severe fever using placebo as a parallel control
初步评价双翘感冒颗粒治疗普通感冒(风热证)伴中重度发热的有效性及安全性,同时进行剂量探索,为Ⅲ期临床试验提供合适的剂量参考。
[Translation] To preliminarily evaluate the effectiveness and safety of Shuangqiao Cold Granules in treating the common cold (wind-heat syndrome) accompanied by moderate to severe fever, and to conduct dose exploration to provide a suitable dose reference for Phase III clinical trials.
评价双翘感冒颗粒治疗中重度普通感冒(风热证)发热的有效性及安全性随机、双盲、安慰剂对照的Ⅱ期临床试验
[Translation] A randomized, double-blind, placebo-controlled phase II clinical trial to evaluate the efficacy and safety of Shuangqiao Ganmao Granules in the treatment of moderate to severe common cold (wind-heat syndrome) with fever
初步评价双翘感冒颗粒治疗中重度普通感冒(风热证)发热的有效性及安全性,同时进行剂量探索,为Ⅲ期临床试验提供合适的剂量参考。
[Translation] To preliminarily evaluate the effectiveness and safety of Shuangqiao Cold Granules in treating moderate to severe common cold (wind-heat syndrome) with fever, and to conduct dose exploration to provide a suitable dose reference for Phase III clinical trials.
100 Clinical Results associated with Huixian Baiquan Traditional Chinese Medicine Research and Development Co., Ltd.
0 Patents (Medical) associated with Huixian Baiquan Traditional Chinese Medicine Research and Development Co., Ltd.
100 Deals associated with Huixian Baiquan Traditional Chinese Medicine Research and Development Co., Ltd.
100 Translational Medicine associated with Huixian Baiquan Traditional Chinese Medicine Research and Development Co., Ltd.